Related Experiment Video
Updated: Jun 7, 2026
10:37
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Short-term effect of changes in smoking behaviour on emphysema quantification by CT
Haseem Ashraf1, Pechin Lo, Saher Burhan Shaker
1Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark. haseem.ashraf@gmail.com
Thorax
|October 28, 2010
Summary
Smoking cessation significantly decreases lung density, while relapse increases it. Lung density changes after quitting or resuming smoking are crucial for accurately assessing emphysema severity using CT scans.
Area of Science:
- Pulmonary Medicine
- Radiology
- Public Health
Background:
- Smoking significantly impacts lung health and density.
- Low-dose computed tomography (CT) is a key tool for lung imaging.
- Understanding lung density changes related to smoking status is vital.
Purpose of the Study:
- To investigate the effects of smoking cessation and relapse on lung density.
- To quantify lung density changes over time after smoking cessation or relapse.
- To inform the interpretation of CT-based lung density measurements in smokers.
Main Methods:
- Utilized spiral, multidetector, low-dose CT on 726 current and former smokers (>20 pack-years).
- Quantified lung density using 15th percentile density (PD15), adjusted for total lung capacity.
- Employed linear regression models to analyze changes in lung density.
Main Results:
- Baseline lung density (PD15) was higher in current smokers (55 g/l) than former smokers (45 g/l).
- Following smoking cessation, PD15 decreased significantly in the first two years.
- Relapse to smoking led to an increase in PD15 within the first year.
Conclusions:
- Current smoking status profoundly influences lung density as measured by CT.
- Observed differences in lung density between current and former smokers align with changes post-cessation.
- CT lung density assessments for diseases like emphysema must consider smoking status and time since cessation or relapse.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...